Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
DE:PHG
Stock Latest News
Ratings
Pharming Group: Buy Rating Maintained and Strategy Intact Despite Surprise CEO Departure; Price Target Reaffirmed at $38
4d ago
PHAR
Premium
The Fly
Pharming announces CEO Fabrice Chouraqui to step down
5d ago
PHAR
Premium
The Fly
Pharming announces FDA acceptance, Priority review of sNDA for Joenja
9d ago
PHAR
Premium
The Fly
Pharming’s initial Phase 2 Leniolisib data ‘encouraging,’ says H.C. Wainwright
12d ago
PHAR
Premium
The Fly
Pharming announces ‘positive’ Phase 2 topline data for leniolisib in PIDs
12d ago
PHAR
Premium
The Fly
FDA approves Joenja tablets for children aged 4-11 with APDS
23d ago
PHAR
Premium
The Fly
Pharming price target raised to $38 from $37 at Canaccord
2M ago
PHAR
Premium
The Fly
Pharming cuts FY26 revenue view to $375M-$395M from $405M-$425M
2M ago
PHAR
Premium
The Fly
Pharming reports Q2 EPS 2c, consensus 6c
2M ago
PHAR
Premium
Ratings
Buy Rating Reaffirmed on Joenja’s European Expansion and Pediatric FDA Catalyst; $37 Price Target Maintained
3M ago
PHAR
Premium
Ratings
Pharming: Profitable Core, Advancing Pipeline Underpin Buy Rating and Maintained $37 Price Target
3M ago
PHAR
Premium
Company Announcements
Pharming Wins FDA Review for Joenja Pediatric sNDA in APDS
4M ago
6K
PHAR
Premium
Company Announcements
Pharming Group appoints KPMG as new auditor as shareholders back full AGM agenda
4M ago
6K
PHAR
Premium
Ratings
Pantginis Reiterates Buy on Pharming as Joenja’s Global Expansion Advances; $37 Price Target Maintained
4M ago
PHAR
Premium
Company Announcements
Pharming Wins EU Green Light for Joenja, First Approved Treatment for APDS
4M ago
6K
PHAR
Premium
The Fly
Pharming’s Joenja granted marketing authorization by European Commission
4M ago
PHAR
Premium
The Fly
Pharming price target lowered to $40 from $41 at Oppenheimer
5M ago
PHAR
Premium
The Fly
Pharming reports Q1 EPS 1c, consensus 0c
5M ago
PHAR
Premium
The Fly
Pharming sees FY26 revenue $405M-$425M, consensus $411.9M
5M ago
PHAR
Premium
Company Announcements
Pharming Posts Mixed Q1 2026 as Joenja® Growth Offsets RUCONEST® Decline and Global Label Expansion Advances
5M ago
6K
PHAR
Premium
Company Announcements
Pharming Group Showcases New Leniolisib Data and Expands Immunology Focus at CIS 2026
5M ago
6K
PHAR
Premium
Company Announcements
Pharming Group Sets May 28, 2026 AGM With Key Governance and Capital Measures on Agenda
6M ago
6K
PHAR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
